BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Diagnosis
23 results:

  • 1. Undiagnosed cancer Cases in the US During the First 10 Months of the COVID-19 Pandemic.
    Burus T; Lei F; Huang B; Christian WJ; Hull PC; Ellis AR; Slavova S; Tucker TC; Lang Kuhs KA
    JAMA Oncol; 2024 Apr; 10(4):500-507. PubMed ID: 38386344
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Improving the diagnostic process for patients with possible bladder and kidney cancer: a mixed-methods study to identify potential missed diagnostic opportunities.
    Zhou Y; Singh H; Hamilton W; Archer S; Tan S; Brimicombe J; Lyratzopoulos G; Walter FM
    Br J Gen Pract; 2023 Aug; 73(733):e575-e585. PubMed ID: 37253628
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Diagnostic Yield of CT Urography in the Workup of Hematuria With Negative Cystoscopy [Formula: see text].
    Common J; Ramonas M; Alabousi A
    Can Assoc Radiol J; 2021 Nov; 72(4):728-735. PubMed ID: 32615787
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Patterns of Postdiagnosis Depression Among Late-Stage cancer Patients: Do Racial/Ethnic and Sex Disparities Exist?
    Huo J; Bian J; Xie Z; Hong YR; Wilkie DJ; Pereira DB
    Am J Clin Oncol; 2019 Aug; 42(8):675-681. PubMed ID: 31305288
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical characteristics, treatment pattern, and medical costs associated with metastatic castration-resistant prostate cancer in Chinese tertiary care hospital settings.
    Qian Z; Wang Y; Tang Z; Ren D; Wang Z; Chen W; Li Z
    J Med Econ; 2019 Aug; 22(8):728-735. PubMed ID: 30913930
    [No Abstract]    [Full Text] [Related]  

  • 6. Health inequities and cancer survival in Manizales, Colombia: a population-based study.
    Arias-Ortiz NE; de Vries E
    Colomb Med (Cali); 2018 Mar; 49(1):63-72. PubMed ID: 29983465
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Role of Surveillance Biopsy with No cancer as a Prognostic Marker for Reclassification: Results from the Canary prostate Active Surveillance Study.
    Kearns JT; Faino AV; Newcomb LF; Brooks JD; Carroll PR; Dash A; Ellis WJ; Fabrizio M; Gleave ME; Morgan TM; Nelson PS; Thompson IM; Wagner AA; Zheng Y; Lin DW
    Eur Urol; 2018 May; 73(5):706-712. PubMed ID: 29433973
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Occurrence of Malnutrition and Associated Factors in Community-Dwelling Older Adults: Those with a Recent diagnosis of cancer Are at Higher Risk.
    Van Den Broeke C; De Burghgraeve T; Ummels M; Gescher N; Deckx L; Tjan-Heijnen V; Buntinx F; van den Akker M
    J Nutr Health Aging; 2018; 22(2):191-198. PubMed ID: 29380845
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Biparametric 3T Magnetic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2?
    Stanzione A; Imbriaco M; Cocozza S; Fusco F; Rusconi G; Nappi C; Mirone V; Mangiapia F; Brunetti A; Ragozzino A; Longo N
    Eur J Radiol; 2016 Dec; 85(12):2269-2274. PubMed ID: 27842676
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Circulating Beta-2 Microglobulin and Risk of cancer: The Atherosclerosis Risk in Communities Study (ARIC).
    Prizment AE; Linabery AM; Lutsey PL; Selvin E; Nelson HH; Folsom AR; Church TR; Drake CG; Platz EA; Joshu C
    Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):657-64. PubMed ID: 26908438
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma.
    Lim C; Flood TA; Hakim SW; Shabana WM; Quon JS; El-Khodary M; Thornhill RE; El Hallani S; Schieda N
    J Magn Reson Imaging; 2016 Mar; 43(3):726-36. PubMed ID: 26303719
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genetic variations in genes involved in testosterone metabolism are associated with prostate cancer progression: A Spanish multicenter study.
    Henríquez-Hernández LA; Valenciano A; Foro-Arnalot P; Álvarez-Cubero MJ; Cozar JM; Suárez-Novo JF; Castells-Esteve M; Fernández-Gonzalo P; De-Paula-Carranza B; Ferrer M; Guedea F; Sancho-Pardo G; Craven-Bartle J; Ortiz-Gordillo MJ; Cabrera-Roldán P; Rodríguez-Melcón JI; Herrera-Ramos E; Rodríguez-Gallego C; Lara PC
    Urol Oncol; 2015 Jul; 33(7):331.e1-7. PubMed ID: 25960412
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The cutoff level of free/total prostate specific antigen (f/t PSA) ratios in the diagnosis of prostate cancer: a validation study on a Turkish patient population in different age categories.
    Erol B; Gulpinar MT; Bozdogan G; Ozkanli S; Onem K; Mungan G; Bektas S; Tokgoz H; Akduman B; Mungan A
    Kaohsiung J Med Sci; 2014 Nov; 30(11):545-50. PubMed ID: 25458043
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pathway analysis of genome-wide association study on serum prostate-specific antigen levels.
    Ge YZ; Xu Z; Xu LW; Yu P; Zhao Y; Xin H; Wu R; Tan SJ; Song Q; Wu JP; Li WC; Zhu JG; Jia RP
    Gene; 2014 Nov; 551(1):86-91. PubMed ID: 25168891
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Baseline serum 25-hydroxyvitamin d levels in men undergoing radical prostatectomy: is there an association with adverse pathologic features?
    Berg WT; Shapiro EY; Rothberg MB; Bergman A; Scarberry K; Wambi C; Patel T; Badani KK
    Clin Genitourin Cancer; 2014 Oct; 12(5):330-4. PubMed ID: 24680790
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer.
    Lyratzopoulos G; Abel GA; Brown CH; Rous BA; Vernon SA; Roland M; Greenberg DC
    Ann Oncol; 2013 Mar; 24(3):843-50. PubMed ID: 23149571
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Effectiveness of the combined evaluation of KLK3 genetics and free-to-total prostate specific antigen ratio for prostate cancer diagnosis.
    Zambon CF; Prayer-Galetti T; Basso D; Padoan A; Rossi E; Secco S; Pelloso M; Fogar P; Navaglia F; Moz S; Zattoni F; Plebani M
    J Urol; 2012 Oct; 188(4):1124-30. PubMed ID: 22901566
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparison of modifiable health behaviours between persons with and without cancer: the Multiethnic Cohort.
    Ollberding NJ; Maskarinec G; Wilkens LR; Henderson BE; Kolonel LN
    Public Health Nutr; 2011 Oct; 14(10):1796-804. PubMed ID: 21208497
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis.
    Hellgren K; Smedby KE; Feltelius N; Baecklund E; Askling J
    Arthritis Rheum; 2010 May; 62(5):1252-8. PubMed ID: 20155827
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Association of a positive family history with histopathology and clinical course in early-onset prostate cancer].
    Herkommer K; Paiss T; Merz M; Gschwend JE; Kron M
    Urologe A; 2006 Dec; 45(12):1532-9. PubMed ID: 17004091
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.